• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Executives Sell Over $640M Of 5 Stocks

    3/30/22 1:08:21 PM ET
    $AMP
    $APR
    $CRC
    $INSP
    Investment Managers
    Finance
    Medical/Dental Instruments
    Health Care
    Get the next $AMP alert in real time by email


    Although oil futures traded higher on Wednesday, there were a few notable insider trades.

    When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

    Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

    Inspire Medical Systems

    • The Trade: Inspire Medical Systems, Inc. (NYSE:INSP) CEO and President Timothy P Herbert sold a total of 130,000 shares at an average price of $250.52. The insider received around $32.57 million from selling those shares.
    • What’s Happening: Inspire Medical Systems, last month, generated revenue of $78.39 million in Q4, a 70% Y/Y increase, marginally beating the consensus of $78.11 million and in line with the management expectation.
    • What Inspire Medical Systems Does: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA).

    Ameriprise Financial

    • The Trade: Ameriprise Financial, Inc. (NYSE:AMP) Chairman and CEO James M Cracchiolo sold a total of 56,622 shares at an average price of $314.16. The insider received around $17.79 million from selling those shares.
    • What’s Happening: Piper Sandler, earlier during the month, downgraded the stock from Overweight to Neutral and lowered its price target from $370 to $325.
    • What Ameriprise Financial Does: Spun off from American Express in 2005, Ameriprise Financial has emerged as a major player in the U.S. market for asset and wealth management, with around $1.4 trillion in total assets under management and advisement at the end of 2021.

    Also check this: Executives Buy Around $39M Of 4 Stocks

    Apria

    • The Trade: Apria, Inc. (NASDAQ:APR) 10% owner Stephen Schwarzman sold a total of 14,187,515 shares at an average price of $37.50. The insider received around $532.03 million as a result of the transaction.
    • What’s Happening: The company, last month, posted mixed quarterly results.
    • What Apria Does: Apria Inc is a provider of integrated home healthcare equipment and related services in the United States.

    California Resources

    • The Trade: California Resources Corporation (NYSE:CRC) 10% owner Steven Tananbaum sold a total of 609,209 shares at an average price of $49.35. The insider received around $30.07 million from selling those shares.
    • What’s Happening: The company, last month, posted upbeat quarterly sales.
    • What California Resources Does: California Resources Corp is an independent oil and natural gas company committed to energy transition in the sector. The firm has some of the lowest carbon intensity production in the US.

    NVIDIA

    • The Trade: NVIDIA Corporation (NASDAQ:NVDA) Director Tench Coxe sold a total of 100,000 shares at an average price of $274.06. The insider received around $27.41 million from selling those shares.
    • What’s Happening: Tigress Financial recently maintained a Buy rating on the stock and raised its price target from $400 to $410.
    • What NVIDIA Does: Nvidia is the top designer of discrete graphics processing units that enhance the experience on computing platforms. The firm's chips are used in a variety of end markets, including high-end PCs for gaming, data centers, and automotive infotainment systems.
    Get the next $AMP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMP
    $APR
    $CRC
    $INSP

    CompanyDatePrice TargetRatingAnalyst
    Inspire Medical Systems Inc.
    $INSP
    2/12/2026$74.00Outperform → Neutral
    Robert W. Baird
    Inspire Medical Systems Inc.
    $INSP
    2/12/2026$70.00Overweight → Equal Weight
    Wells Fargo
    Ameriprise Financial Inc.
    $AMP
    1/30/2026$530.00Underweight → Neutral
    Piper Sandler
    Inspire Medical Systems Inc.
    $INSP
    1/27/2026$90.00Outperform → Sector Perform
    RBC Capital Mkts
    Inspire Medical Systems Inc.
    $INSP
    1/22/2026$96.00Buy → Hold
    Truist
    Inspire Medical Systems Inc.
    $INSP
    1/22/2026Outperform → Perform
    Oppenheimer
    NVIDIA Corporation
    $NVDA
    1/15/2026$240.00Outperform
    RBC Capital Mkts
    California Resources Corporation
    $CRC
    1/9/2026Outperform → Neutral
    Pickering Energy Partners
    More analyst ratings

    $AMP
    $APR
    $CRC
    $INSP
    SEC Filings

    View All

    Ameriprise Financial Inc. filed SEC Form 8-K: Leadership Update

    8-K - AMERIPRISE FINANCIAL INC (0000820027) (Filer)

    2/12/26 4:27:30 PM ET
    $AMP
    Investment Managers
    Finance

    Inspire Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Inspire Medical Systems, Inc. (0001609550) (Filer)

    2/11/26 4:32:10 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by Inspire Medical Systems Inc.

    SCHEDULE 13G - Inspire Medical Systems, Inc. (0001609550) (Subject)

    2/10/26 11:17:43 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    $AMP
    $APR
    $CRC
    $INSP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Seligman Investments Launches $500M Venture Capital Arm

    Led by Veteran Investor Umesh Padval, Seligman Ventures expands Seligman Investments' technology investing platform into venture capital Seligman Investments ("Seligman"), the Silicon Valley-based technology investor led by Chief Investment Officer Paul Wick, today announced the launch of Seligman Ventures, a new venture capital arm designed to invest across early-stage to pre-IPO technology companies in the AI and cloud infrastructure, cybersecurity, and modern data-center hardware verticals. The launch represents a strategic expansion of Seligman's technology investing platform into venture capital, complementing the firm's long-standing public markets expertise with investments in inno

    2/12/26 9:00:00 AM ET
    $AMP
    $MPWR
    $PI
    Investment Managers
    Finance
    Semiconductors
    Technology

    Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42Operating cash flow of $52.5 million in the fourth quarter with full year operating cash flow of $117.0 million MINNEAPOLIS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and

    2/11/26 4:02:00 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Ameriprise Financial Chief Financial Officer to Present at the 2026 Bank of America Securities Financial Services Conference

    Ameriprise Financial, Inc. (NYSE:AMP) announced today that Walter S. Berman, executive vice president and chief financial officer, is scheduled to speak about the company's business and strategy at the 2026 Bank of America Securities Financial Services Conference on Wednesday, February 11, 2026 at approximately 1 p.m. ET. A live webcast of the fireside chat will be available on the Ameriprise Financial Investor Relations website at ir.ameriprise.com. At Ameriprise Financial, we have been helping people feel confident about their financial future for more than 130 years. With extensive investment advice, global asset management capabilities and insurance solutions, and a nationwide netwo

    2/4/26 4:30:00 PM ET
    $AMP
    Investment Managers
    Finance

    $AMP
    $APR
    $CRC
    $INSP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Inspire Medical Systems downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Inspire Medical Systems from Outperform to Neutral and set a new price target of $74.00

    2/12/26 7:22:54 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Inspire Medical Systems downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Inspire Medical Systems from Overweight to Equal Weight and set a new price target of $70.00

    2/12/26 7:22:44 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Ameriprise Financial upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Ameriprise Financial from Underweight to Neutral and set a new price target of $530.00

    1/30/26 6:39:58 AM ET
    $AMP
    Investment Managers
    Finance

    $AMP
    $APR
    $CRC
    $INSP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, GLOBAL ASSET MANAGEMENT Truscott William F sold $2,660,400 worth of shares (5,000 units at $532.08) (SEC Form 4)

    4 - AMERIPRISE FINANCIAL INC (0000820027) (Issuer)

    2/12/26 4:29:03 PM ET
    $AMP
    Investment Managers
    Finance

    Officer Weatherby Carlton covered exercise/tax liability with 327 shares, decreasing direct ownership by 4% to 7,130 units (SEC Form 4)

    4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

    2/11/26 5:23:36 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Officer Phillips Bryan K covered exercise/tax liability with 327 shares, decreasing direct ownership by 2% to 13,070 units (SEC Form 4)

    4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

    2/11/26 5:21:39 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    $AMP
    $APR
    $CRC
    $INSP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 21, 2023 - FDA Roundup: March 21, 2023

    For Immediate Release: March 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA completed its second pre-market consultation for a human food made from cultured animal cells. The firm will use animal cell culture technology to take living cells from chickens and grow the cells in a controlled environment to make the cultured

    3/21/23 3:12:46 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    $AMP
    $APR
    $CRC
    $INSP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Curet Myriam bought $804 worth of shares (5 units at $160.72) and sold $616 worth of shares (6 units at $102.59), decreasing direct ownership by 0.03% to 3,365 units (SEC Form 4)

    4 - Inspire Medical Systems, Inc. (0001609550) (Issuer)

    11/24/25 8:40:17 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Director Roby William B bought $22,227 worth of shares (467 units at $47.62), increasing direct ownership by 0.82% to 57,179 units (SEC Form 4)

    4 - California Resources Corp (0001609253) (Issuer)

    11/13/25 4:48:18 PM ET
    $CRC
    Oil & Gas Production
    Energy

    President and CEO Leon Francisco bought $258,816 worth of shares (5,425 units at $47.71), increasing direct ownership by 2% to 304,834 units (SEC Form 4)

    4 - California Resources Corp (0001609253) (Issuer)

    11/12/25 4:36:39 PM ET
    $CRC
    Oil & Gas Production
    Energy

    $AMP
    $APR
    $CRC
    $INSP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ameriprise Financial Inc.

    SC 13G/A - AMERIPRISE FINANCIAL INC (0000820027) (Filed by)

    11/14/24 12:28:27 PM ET
    $AMP
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Ameriprise Financial Inc.

    SC 13G/A - AMERIPRISE FINANCIAL INC (0000820027) (Filed by)

    11/14/24 12:26:25 PM ET
    $AMP
    Investment Managers
    Finance

    SEC Form SC 13G filed by Ameriprise Financial Inc.

    SC 13G - AMERIPRISE FINANCIAL INC (0000820027) (Filed by)

    11/14/24 12:16:49 PM ET
    $AMP
    Investment Managers
    Finance

    $AMP
    $APR
    $CRC
    $INSP
    Financials

    Live finance-specific insights

    View All

    Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42Operating cash flow of $52.5 million in the fourth quarter with full year operating cash flow of $117.0 million MINNEAPOLIS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and

    2/11/26 4:02:00 PM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Ameriprise Financial Declares Regular Quarterly Dividend

    The Board of Directors of Ameriprise Financial, Inc. (NYSE:AMP) has declared a quarterly cash dividend of $1.60 per common share payable on February 27, 2026 to shareholders of record at the close of business on February 9, 2026. At Ameriprise Financial, we have been helping people feel confident about their financial future for more than 130 years. With extensive investment advice, global asset management capabilities and insurance solutions, and a nationwide network of more than 10,000 financial advisors, we have the strength and expertise to serve the full range of individual and institutional investors' financial needs. © 2026 Ameriprise Financial, Inc. All rights reserved. View so

    1/29/26 6:31:00 AM ET
    $AMP
    Investment Managers
    Finance

    Ameriprise Financial Reports Fourth Quarter and Full Year 2025 Results

    Ameriprise Financial, Inc. (NYSE:AMP): Earnings Per Diluted Share   Return on Equity, ex AOCI (1)   Q4 2025   FY 2025     Q4 2025 GAAP $10.47   $36.28   GAAP 49.1% Adjusted Operating $10.83   $39.29   Adjusted Operating 53.2%               Fourth quarter adjusted operating earnings per diluted share increased 16 percent to a record $10.83. Results reflected continued asset growth and expense discipline. Full year 2025 adjusted operating earnings per diluted share increased 14 percent to $3

    1/29/26 6:30:00 AM ET
    $AMP
    Investment Managers
    Finance

    $AMP
    $APR
    $CRC
    $INSP
    Leadership Updates

    Live Leadership Updates

    View All

    Experienced Team With $120 Million in Assets Joins Ameriprise Financial for Enhanced Client Experience and Operational Efficiency

    Ameriprise welcomes Loveday Caruso Wealth Management Group from LPL Financial Financial advisory practice Loveday Caruso Wealth Management Group recently joined the independent channel of Ameriprise Financial, Inc. (NYSE:AMP) from LPL Financial with $120 million in assets. The practice, based in Littleton, Colo., is led by private wealth advisor Sean Loveday, ChFC®, CLU®, and includes financial advisor Sarah Caruso and administrative assistant Lori O'Halloran. The team's decision to join Ameriprise was driven by their commitment to enhancing the client experience and improving operational efficiency. Loveday outlined several key reasons for making the move: Client-Centered Technology

    1/12/26 12:13:00 PM ET
    $AMP
    Investment Managers
    Finance

    Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance

    MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire", or the "Company"), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced certain preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025, and provided its initial full year 2026 revenue guidance. Further, the Company announced the appointment of Matt Osberg as Executive Vice President and Chief Financial Officer. Preliminary, Unaudited Fourth Quarter and Full Year 2025 Revenue Revenue for the fourth quarter of 2025 is anticipate

    1/12/26 6:45:00 AM ET
    $INSP
    Medical/Dental Instruments
    Health Care

    Growth Opportunities and Robust Resources Draw Four Advisors Managing Nearly $300 Million in Client Assets to Ameriprise Financial

    The advisors join Kuttin Wealth Management, a well-established Ameriprise team led by private wealth advisor Jon Kuttin Ameriprise Financial, Inc. (NYSE:AMP) recently welcomed four experienced financial advisors who collectively manage nearly $300 million in client assets. The advisors have joined Kuttin Wealth Management, a well-established team within Ameriprise's independent channel led by Barron's Hall of Fame advisor Jon Kuttin, CRPC™, AAMS®, AWMA®, CMFC™, CRPS™, APMA®. Kevin Kitt Joins from UBS Financial Services Financial advisor Kevin Kitt, CFP® who manages more than $110 million in client assets, has joined the practice in Westhampton Beach, N.Y. from UBS Financial Services. For

    12/11/25 2:57:00 PM ET
    $AMP
    Investment Managers
    Finance